MRI Can Halve Prostate Cancer Over-Diagnosis
|
By MedImaging International staff writers Posted on 29 Jul 2021 |
|
Image: MRI screening can significantly reduce prostate cancer over-diagnoses (Photo courtesy of Getty Images)
A new study suggests that screening by magnetic resonance imaging (MRI) and targeted biopsies could significantly reduce prostate cancer (PC) over-diagnosis.
Researchers at Karolinska Institutet (Solna, Sweden) and Karolinska University Hospital (Stockholm, Sweden) conducted a population-based study of 12,750 (50 to 74 years of age). Those with prostate-specific antigen (PSA) levels of 3 ng/ml or higher were randomly assigned to undergo standard biopsy or MRI, with targeted biopsy added if MRI results suggested PC. The primary outcome was proportion of men in whom clinically significant PC was diagnosed; a key secondary outcome was the detection of clinically insignificant cancers.
The results showed that 1,532 men had PSA levels of 3 ng/ml or higher; 603 were assigned to the standard biopsy group and 929 to the targeted biopsy group. In intention-to-treat analysis, clinically significant cancer was diagnosed in 21% in the targeted biopsy group, as compared with 18% in the standard biopsy group. The percentage of clinically insignificant cancers was lower in the targeted biopsy group (4%) than in the standard biopsy group (12%). The study was published on July 9, 2021, in The New England Journal of Medicine (NEJM).
“High rates of overdiagnosis are a critical barrier to organized PC screening. Most countries have not introduced nationwide PC screening, as current methods result in over-diagnoses and excessive and unnecessary biopsies,” said lead author urologist Tobias Nordström, PhD, of Karolinska Institutet. “Our results show that modern methods for PC screening maintain the benefits of screening, while decreasing the harms substantially. This addresses the greatest barrier to the introduction of nationwide screening.”
Current PC screening methods, which include prostate-specific antigen (PSA) tests combined with traditional biopsies, often result in unnecessary biopsies, and the detection of numerous minor low-risk tumors. Consequently, no country except Lithuania has chosen to introduce a nationwide PC screening programme, as the benefits do not exceed the disadvantages.
Related Links:
Karolinska Institutet
Karolinska University Hospital
Researchers at Karolinska Institutet (Solna, Sweden) and Karolinska University Hospital (Stockholm, Sweden) conducted a population-based study of 12,750 (50 to 74 years of age). Those with prostate-specific antigen (PSA) levels of 3 ng/ml or higher were randomly assigned to undergo standard biopsy or MRI, with targeted biopsy added if MRI results suggested PC. The primary outcome was proportion of men in whom clinically significant PC was diagnosed; a key secondary outcome was the detection of clinically insignificant cancers.
The results showed that 1,532 men had PSA levels of 3 ng/ml or higher; 603 were assigned to the standard biopsy group and 929 to the targeted biopsy group. In intention-to-treat analysis, clinically significant cancer was diagnosed in 21% in the targeted biopsy group, as compared with 18% in the standard biopsy group. The percentage of clinically insignificant cancers was lower in the targeted biopsy group (4%) than in the standard biopsy group (12%). The study was published on July 9, 2021, in The New England Journal of Medicine (NEJM).
“High rates of overdiagnosis are a critical barrier to organized PC screening. Most countries have not introduced nationwide PC screening, as current methods result in over-diagnoses and excessive and unnecessary biopsies,” said lead author urologist Tobias Nordström, PhD, of Karolinska Institutet. “Our results show that modern methods for PC screening maintain the benefits of screening, while decreasing the harms substantially. This addresses the greatest barrier to the introduction of nationwide screening.”
Current PC screening methods, which include prostate-specific antigen (PSA) tests combined with traditional biopsies, often result in unnecessary biopsies, and the detection of numerous minor low-risk tumors. Consequently, no country except Lithuania has chosen to introduce a nationwide PC screening programme, as the benefits do not exceed the disadvantages.
Related Links:
Karolinska Institutet
Karolinska University Hospital
Gold Member
Ultrasound System
FUTUS LE
Gold Member
Electrode Solution and Skin Prep
Signaspray
Ferromagnetic Hand-Held Detector
FerrAlert Target Scanner
Forensic Imaging System
EXERO-DR
Latest MRI News
- PET/MRI Improves Diagnostic Accuracy for Prostate Cancer Patients
- Next Generation MR-Guided Focused Ultrasound Ushers In Future of Incisionless Neurosurgery
- Two-Part MRI Scan Detects Prostate Cancer More Quickly without Compromising Diagnostic Quality
- World’s Most Powerful MRI Machine Images Living Brain with Unrivaled Clarity
- New Whole-Body Imaging Technology Makes It Possible to View Inflammation on MRI Scan
- Combining Prostate MRI with Blood Test Can Avoid Unnecessary Prostate Biopsies
- New Treatment Combines MRI and Ultrasound to Control Prostate Cancer without Serious Side Effects
- MRI Improves Diagnosis and Treatment of Prostate Cancer
- Combined PET-MRI Scan Improves Treatment for Early Breast Cancer Patients
- 4D MRI Could Improve Clinical Assessment of Heart Blood Flow Abnormalities
- MRI-Guided Focused Ultrasound Therapy Shows Promise in Treating Prostate Cancer
- AI-Based MRI Tool Outperforms Current Brain Tumor Diagnosis Methods
- DW-MRI Lights up Small Ovarian Lesions like Light Bulbs
- Abbreviated Breast MRI Effective for High-Risk Screening without Compromising Diagnostic Accuracy
- New MRI Method Detects Alzheimer’s Earlier in People without Clinical Signs
- MRI Monitoring Reduces Mortality in Women at High Risk of BRCA1 Breast Cancer
Channels
Radiography
view channel
Novel Breast Imaging System Proves As Effective As Mammography
Breast cancer remains the most frequently diagnosed cancer among women. It is projected that one in eight women will be diagnosed with breast cancer during her lifetime, and one in 42 women who turn 50... Read more
AI Assistance Improves Breast-Cancer Screening by Reducing False Positives
Radiologists typically detect one case of cancer for every 200 mammograms reviewed. However, these evaluations often result in false positives, leading to unnecessary patient recalls for additional testing,... Read more
Ultrasound
view channel
Deep Learning Advances Super-Resolution Ultrasound Imaging
Ultrasound localization microscopy (ULM) is an advanced imaging technique that offers high-resolution visualization of microvascular structures. It employs microbubbles, FDA-approved contrast agents, injected... Read more
Novel Ultrasound-Launched Targeted Nanoparticle Eliminates Biofilm and Bacterial Infection
Biofilms, formed by bacteria aggregating into dense communities for protection against harsh environmental conditions, are a significant contributor to various infectious diseases. Biofilms frequently... Read more
Nuclear Medicine
view channel
New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more
New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
Ovarian cancer is the most lethal gynecological cancer, with less than a 30% five-year survival rate for those diagnosed in late stages. Despite surgery and platinum-based chemotherapy being the standard... Read more
AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more
General/Advanced Imaging
view channel
New AI Method Captures Uncertainty in Medical Images
In the field of biomedicine, segmentation is the process of annotating pixels from an important structure in medical images, such as organs or cells. Artificial Intelligence (AI) models are utilized to... Read more.jpg "Image: CT coronary angiography for diagnosing coronary artery disease offers advantages over other diagnostic tests (Photo courtesy of 123RF)")
CT Coronary Angiography Reduces Need for Invasive Tests to Diagnose Coronary Artery Disease
Coronary artery disease (CAD), one of the leading causes of death worldwide, involves the narrowing of coronary arteries due to atherosclerosis, resulting in insufficient blood flow to the heart muscle.... Read more
Novel Blood Test Could Reduce Need for PET Imaging of Patients with Alzheimer’s
Alzheimer's disease (AD), a condition marked by cognitive decline and the presence of beta-amyloid (Aβ) plaques and neurofibrillary tangles in the brain, poses diagnostic challenges. Amyloid positron emission... Read more.jpg "Image: Exemplary illustration of the labeling and segmentation process (Photo courtesy of TUM)")
CT-Based Deep Learning Algorithm Accurately Differentiates Benign From Malignant Vertebral Fractures
The rise in the aging population is expected to result in a corresponding increase in the prevalence of vertebral fractures which can cause back pain or neurologic compromise, leading to impaired function... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read more
Industry News
view channel
Bayer and Google Partner on New AI Product for Radiologists
Medical imaging data comprises around 90% of all healthcare data, and it is a highly complex and rich clinical data modality and serves as a vital tool for diagnosing patients. Each year, billions of medical... Read more
